Basis of Presentation (Tables)

6 Months Ended

Jun. 30, 2024

Accounting Policies [Abstract]

Schedule of Indefinite-Lived Intangible Assets

U.S. Method Patent	13.4 years
Web Domain	Indefinite life
Trademark	Indefinite life

Schedule of Revenue Recognition

The Company’s revenues consisted of the following:

	For the Three Months Ended				For the Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Allergy Diagnostic Kit Sales	$	190,994	$	192,319	$	428,060	$	387,826
Immunotherapy Treatment Sales		92,482		105,296		178,807		198,770
Subscription Revenue		14,339		18,951		32,709		39,412
Integrated Service Program		160,448		78,737		287,452		113,204
Training and other revenue		5,949		-		15,812		-
Shipping and handling		8,861		9,466		18,820		18,356
Total revenue	$	473,073	$	404,769	$	961,660	$	757,568